S. Korean stem cell firm enters into an agreement with Tiantan Puhua Neurological Hospital in China

RNL Bio entered into an agreement with Tiantan Puhua Neurological Hospital for stem cell treatment of spinal cord injury and more

Source: RNL Biostar, Inc
Feb 04, 2008 14:10:15


(PRLog.Org) – Feb 04, 2008 – RNL Bio, Co., LTD., (RNL), a leading stem cell therapeutics company of Korea, has entered today into an agreement with Tiantan Puhua Neurological Hospital (Puhua) in Beijing, China to establish a joint venture (the firm) and a new hospital to provide patients with stem cell therapeutics.
Dr. Sherwood Yang, Vice president of Puhua agreed with Dr. Jeong Chan Ra, president of CEO of RNL, to open a new stem cell clinic within Puhua hospital through the firm. The new hospital was tentatively named as “RNL-Puhua Stem Cell Medical Center, and will provide stem cell treatments of various degenerative disease including hair loss, aged face and osteoarthritis. The firm will also supply Puhua hospital with stem cell therapeutics for neurological condition such as spinal cord injury which Puhua is specialized for.
“We are very pleased to have a new hospital for stem cell therapy in China. It will not only advance the commercialization of out stem cell technology but contribute effective stem cell treatment to patients with obsolete complications”, said Dr. Ra.

continue...
http://www.prlog.org/10049157-korean...-in-china.html